USPTO serial 78474638
MAGFORCE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 31, 2009
- Examiner
- CHOSID, ROBIN S
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with MAGFORCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MagForce Nanotechnologies GmbH
Berlin, DE
MagForce Nanotechnologies GmbH
Berlin, DE
MagForce Nanotechnologies GmbH
Berlin, DE
BERLIN, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shauna M. Wertheim, Esq.
Shauna M. Wertheim, Esq. The Marbury Law Group, PLLC11800 SUNRISE VALLEY DR 15th Floor11800 Sunrise Valley Drive, 15th FLReston, VA 20191Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; magnetic nanoparticles, chemical particles having a nanometer size, chemicals and biopolymers containing nanoparticles for use in medical research and science; iron oxide based[ nanodots, nanoprobe, nano-sensing probe,] nanometals, nanoparticles for use in medical research and science; magnetites and maghemites for use in medical research and science | ACTIVE | — |
| 005 | Pharmaceuticals, pharmaceutical [and veterinary] products as well as compounds for healthcare, namely, anti-cancer preparations, preparations for the treatment of benign tumors[ preparations for the treatment or prophylaxis of arthritis, preparations for the treatment or prophylaxis of arthrosis, preparations for the treatment or prophylaxis of stenoses and restenoses, preparations for the treatment or prophylaxis of heart diseases, preparations for the treatment or prophylaxis of skin diseases]; pharmaceutical [and veterinary] products containing magnetic nanoparticles, namely, anti-cancer preparations, preparations for the treatment of benign tumors, [preparations for the treatment or prophylaxis of arthritis, preparations for the treatment or prophylaxis of arthrosis, preparations for the treatment or prophylaxis of stenoses and restenoses, preparations for the treatment or prophylaxis of heart diseases, preparations for the treatment or prophylaxis of skin diseases; contrast agents for medical use,] contrast agents for medical use containing magnetic nanoparticles; agents for diagnostic and medical purposes, namely, for imaging and detection of cancer, tumors,[ arthritis, arthrosis, stenosis, restenosis, heart diseases and skin diseases, ]agents for diagnostic and medical purposes containing magnetic nanoparticles;[ dietary supplements for medical purposes, baby food; medical plaster, dressing material for wounds and surgical use; teeth fillers and casting compounds for dental purposes, adhesives for dental plates, dental cement; deodorants, not for personal use, detergents for medical purposes, medical herb teas, ]chemicals for medical diagnostic use, namely, shift reagents, x-ray contrast agents, marker reagents for radio-spectroscopic and x-ray spectroscopic, UV-, IR-, NMR- and mass spectroscopic measurements | ACTIVE | — |
| 009 | Electronic scientific devices, namely,[ x-ray fluorescence spectrometer; nuclear magnetic resonance spectrometer;] devices for generating an alternating magnetic field;[ optical apparatuses, devices and instruments, namely, monochromators;] information processing equipments and apparatuses, namely, computer hardware; computer software for operating all of the aforementioned devices recorded on magnetic data carriers, CDs, magnetic tape carriers, [laboratory incubators for use in science] | ACTIVE | — |
| 010 | Medical devices and instruments containing magnetic nanoparticles, namely, medical implants, stents, catheters,[ catheter balloons,] implantable drug carrier, implants for sustained drug release, implants for chemo-embolization; medical devices and instruments coated with magnetic nanoparticles, namely, medical implants, stents, catheters, catheter balloons, implantable drug carrier, implants for sustained drug release, implants for chemo-embolization; systems with [magnets of high precision and appendant electronic instrumentations for nuclear magnetic resonance], medical technical devices, namely, hyperthermia devices and devices for local heating as well as components of afore mentioned devices for heating body tissue; hyperthermia systems for cancer treatment, namely, thermotherapy device comprising at least one coil for generating an alternating electromagnetic field; technical devices for stimulation of nanoparticles in an alternating magnetic field, namely, for heating body tissue, for activating pharmaceuticals attached to the nanoparticles, for release of pharmaceuticals attached to the nanoparticles;[ medical instruments and apparatuses, for breathing, namely, oxygen masks and oxygen monitors, anesthesia devices, incubators for medical use, shielding devices for actino-therapeutic, x-ray-, diagnostic-, computertomografic and medical facilities, especially shielding protection walls, radiation protection gates and radiation protection curtains] | ACTIVE | — |
| 042 | Services for scientific and industrial research, provision of scientific literature for research, development and production; development services of nanoparticles, development services of medical devices and instruments coated with nanoparticles, development services of medical devices and instruments containing nanoparticles, development services of nanoproducts; development services referring to new medical devices and accessories for third parties; services for research and development medical devices and accessories; services for quality assurance of medical devices and accessories; analysis of magnetic and electromagnetic measurements for medical purposes, analysis of magnetic resonance tomographic measurements, creation of software for data processing, technical consulting services of third parties in the field of information and medical technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MagForce Nanotechnologies GmbH
- Other trademarks owned by MagForce Nanotechnologies GmbH
- Other trademarks owned by MagForce Nanotechnologies GmbH
- Other trademarks owned by MAGFORCE AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named MAGFORCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2019 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Feb 12, 2019 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 12, 2019 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 12, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 14, 2019 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 31, 2018 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 11, 2015 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 11, 2015 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 8, 2015 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 1, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 23, 2015 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 15, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 31, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 24, 2009 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 9, 2009 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jan 26, 2009 | FAXX | FAX RECEIVED | — |
| Sep 10, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 12, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 23, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 8, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 7, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 7, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jul 7, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 7, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 7, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 5, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 21, 2008 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Mar 27, 2008 | ATRQ | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | — |
| Mar 27, 2008 | ADBS | 1(B) BASIS DELETED; NEW BASIS REQUESTED | — |
| Mar 25, 2008 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Mar 18, 2008 | FAXX | FAX RECEIVED | — |
| Feb 19, 2008 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 22, 2008 | PDCB | PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED | — |
| Jan 22, 2008 | PAPER RECEIVED | — | |
| Jan 16, 2008 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 16, 2007 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 16, 2007 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 16, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 16, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 24, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 4, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 6, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 5, 2006 | ALIE | ASSIGNED TO LIE | — |
| Aug 30, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 30, 2006 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 30, 2006 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 30, 2006 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 16, 2006 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 1, 2006 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 7, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 12, 2006 | ALIE | ASSIGNED TO LIE | — |
| May 8, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 20, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 23, 2005 | GRML | CORRESPONDENCE E-MAILED | — |
| Oct 23, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 29, 2005 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 3, 2004 | NWAP | NEW APPLICATION ENTERED | — |